» Articles » PMID: 17293660

Captopril Reduces Interstitial Renal Fibrosis and Preserves More Normal Renal Tubules in Neonatal Dogs with Partial Urethral Obstruction: a Preliminary Study

Overview
Journal Urol Int
Publisher Karger
Specialty Urology
Date 2007 Feb 13
PMID 17293660
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Chronic renal damage due to tubulointerstitial fibrosis is one of several complications of posterior urethral valves in a significant number of children. As activation of the renin-angiotensin system plays an important role in this injury, we conducted this study to investigate whether administration of captopril reduced renal fibrosis in an experimental model using partial urethral obstruction (PUO) in neonatal dogs.

Material And Methods: Experimental PUO was induced in all pups. These animals were then divided into two groups: in the first group (experimental), captopril 35 mg/kg/day, dissolved in drinking water, was administered for 6 weeks. The second group (positive control) did not receive any treatment. After 6 weeks all dogs underwent left nephrectomy. Volume fraction and absolute volume of the histological kidney parameters, i.e., normal glomerulus, normal tubule, vessels, degenerated glomerulus, degenerated tubule, fibrous tissue, were estimated using modern unbiased stereological methods.

Results: The absolute volume of interstitial fibrosis was lower in the experimental group (PUO with captopril treatment) (approximately 73%; p < 0.008) in comparison with positive control animals (PUO with no treatment). The mean absolute volume of normal tubules in the experimental group was more than the positive control group (approximately 33%, p < 0.008). The mean absolute volume of normal and degenerated glomerulus, vessels and degenerated tubule did not show a significant difference between the two groups.

Conclusion: Administration of captopril decreases interstitial renal fibrosis and preserves renal tubules in neonatal dogs with PUO.

Citing Articles

Lactacystin-induced kidney fibrosis: Protection by melatonin and captopril.

Repova K, Stanko P, Baka T, Krajcirovicova K, Aziriova S, Hrenak J Front Pharmacol. 2022; 13:978337.

PMID: 36176443 PMC: 9513205. DOI: 10.3389/fphar.2022.978337.


Co-Delivery of Dexamethasone and Captopril by α8 Integrin Antibodies Modified Liposome-PLGA Nanoparticle Hybrids for Targeted Anti-Inflammatory/Anti-Fibrosis Therapy of Glomerulonephritis.

Zhou L, Ye Z, Zhang E, Chen L, Hou Y, Lin J Int J Nanomedicine. 2022; 17:1531-1547.

PMID: 35388271 PMC: 8978694. DOI: 10.2147/IJN.S347164.


Current strategies to predict and manage sequelae of posterior urethral valves in children.

Deshpande A Pediatr Nephrol. 2017; 33(10):1651-1661.

PMID: 29159472 DOI: 10.1007/s00467-017-3815-0.


Stereological comparison of the effects of pentoxifylline, captopril, simvastatin, and tamoxifen on kidney and bladder structure after partial urethral obstruction in rats.

Shirazi M, Soltani M, Jahanabadi Z, Abdollahifar M, Tanideh N, Noorafshan A Korean J Urol. 2014; 55(11):756-63.

PMID: 25405019 PMC: 4231154. DOI: 10.4111/kju.2014.55.11.756.


Effects of pentoxifylline on renal structure after urethral obstruction in rat: A stereological study.

Shirazi M, Noorafshan A, Farrokhi A Cent European J Urol. 2014; 64(1):30-3.

PMID: 24578857 PMC: 3921697. DOI: 10.5173/ceju.2011.01.art6.